Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings.

Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings.

To guide future need for cheap resistance tests for use in low income settings, we assessed cost-effectiveness of drug resistance testing as part of monitoring of people on first line ART - with switching from first to second line ART being conditional on NNRTI drug resistance mutations being identi...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Andrew Phillips, Valentina Cambiano, Fumiyo Nakagawa, Travor Mabugu, Alec Miners, Debbie Ford, Deenan Pillay, Andrea De Luca, Jens Lundgren, Paul Revill
Formáid:	Alt
Teanga:	English
Foilsithe / Cruthaithe:	Public Library of Science (PLoS) 2014-01-01
Sraith:	PLoS ONE
Rochtain ar líne:	http://europepmc.org/articles/PMC4188574?pdf=render

Míreanna comhchosúla

Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring.
de réir: Viktor von Wyl, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Projected Lifetime Healthcare Costs Associated with HIV Infection.
de réir: Fumiyo Nakagawa, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic.
de réir: Andrew N Phillips, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Potential future impact of a partially effective HIV vaccine in a southern African setting.
de réir: Andrew N Phillips, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa.
de réir: Andrew N Phillips, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
de réir: Castro Hannah, et al.
Foilsithe / Cruthaithe: (2012-03-01)

‘Dark matter’, second waves and epidemiological modelling
de réir: Deenan Pillay, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Reflecting the real value of health care resources in modelling and cost-effectiveness studies-The example of viral load informed differentiated care.
de réir: Paul Revill, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Preferences for HIV testing services among men who have sex with men in the UK: A discrete choice experiment.
de réir: Alec Miners, et al.
Foilsithe / Cruthaithe: (2019-04-01)

Correction: Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings
Foilsithe / Cruthaithe: (2014-01-01)

Correction: Cost-Effectiveness of HIV Drug Resistance Testing to Inform Switching to Second Line Antiretroviral Therapy in Low Income Settings.
Foilsithe / Cruthaithe: (2014-01-01)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
de réir: Cissy Kityo, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Implications for a policy of initiating antiretroviral therapy in people diagnosed with human immunodeficiency virus: the CAPRA research programme
de réir: Ada Miltz, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Use of surveillance data on HIV diagnoses with HIV-related symptoms to estimate the number of people living with undiagnosed HIV in need of antiretroviral therapy.
de réir: Rebecca K Lodwick, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research
de réir: Dorward, J, et al.
Foilsithe / Cruthaithe: (2018)

The Effect of Antiretroviral Treatment on Health Care Utilization in Rural South Africa: A Population-Based Cohort Study.
de réir: Jan A C Hontelez, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Effect of therapy switch on time to second-line antiretroviral treatment failure in HIV-infected patients.
de réir: Amanda Häggblom, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.
de réir: Phillips, A, et al.
Foilsithe / Cruthaithe: (2004)

Treatment effect and drug-resistant mutations in Chinese AIDS patients switching to second-line antiretroviral therapy.
de réir: Min Zhang, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Incidence of switching to second-line antiretroviral therapy and its predictors among children on antiretroviral therapy at general hospitals, Northern Ethiopia: A survival analysis.
de réir: Migbar Mekonnen Sibhat, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Why do teachers code-switch when teaching English as a second language?
de réir: Sibongile Shinga, et al.
Foilsithe / Cruthaithe: (2021-10-01)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial
de réir: Kityo, C, et al.
Foilsithe / Cruthaithe: (2014)

GUILLAIN-BARRE SYNDROME AS PRESENTATION OF HIV-ASSOCIATED IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER SECOND LINE ANTIRETROVIRAL THERAPY SWITCH
de réir: W.X. Tuang, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Delays in switching patients onto second-line antiretroviral treatment at a public hospital in eThekwini, KwaZulu-Natal
de réir: Denver Narainsamy, et al.
Foilsithe / Cruthaithe: (2017-03-01)

Response to second line antiretroviral therapy in India
de réir: Singh Anup, et al.
Foilsithe / Cruthaithe: (2012-05-01)

HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy
de réir: Steven A. Kemp, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Constructing a greenhouse gas emissions inventory using energy balances: the case of South Africa for 1998
de réir: JN Blignaut, et al.
Foilsithe / Cruthaithe: (2017-10-01)

Effectiveness of interventions aimed at reducing HIV acquisition and transmission among gay and bisexual men who have sex with men (GBMSM) in high income settings: A systematic review.
de réir: Janey Sewell, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Effectiveness of interventions aimed at reducing HIV acquisition and transmission among gay and bisexual men who have sex with men (GBMSM) in high income settings: A systematic review
de réir: Janey Sewell, et al.
Foilsithe / Cruthaithe: (2022-01-01)

Angiolipoma associated with antiretroviral switch therapy: a case report
de réir: Gregory H. Taylor, et al.
Foilsithe / Cruthaithe: (2024-05-01)

Antiretroviral treatment switch strategies for lowering the costs of antiretroviral therapy in subjects with suppressed HIV-1 viremia in Spain
de réir: Llibre JM, et al.
Foilsithe / Cruthaithe: (2013-05-01)

Reasons for disengagement from antiretroviral care in the era of “Treat All” in low‐ or middle‐income countries: a systematic review
de réir: Rachael M. Burke, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Brief communication: The rate of switching from first-line to second-line antiretroviral therapy among people living with HIV in Aden City, Yemen
de réir: Naif Mohammed Al-Haidary, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Switched Convergence of Second-Order Switched Homogeneous Systems
de réir: Carmen Pérez, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Individualization of antiretroviral therapy
de réir: Pavlos R, et al.
Foilsithe / Cruthaithe: (2011-12-01)

Discrete choice experiments: An overview of experience to date in haemophilia
de réir: Spoors John, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Human immunodeficiency virus prevention and testing strategies among men who have sex with men in the UK: the PANTHEON research programme including the SELPHI RCT
de réir: Janey Sewell, et al.
Foilsithe / Cruthaithe: (2024-10-01)

The ethics of switch/simplify in antiretroviral trials: non-inferior or just inferior?
de réir: Andrew Carr, et al.
Foilsithe / Cruthaithe: (2012-01-01)

Assessment of second-line antiretroviral regimens for HIV therapy in Africa
de réir: Paton, N, et al.
Foilsithe / Cruthaithe: (2014)

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.
de réir: Paton, N, et al.
Foilsithe / Cruthaithe: (2014)